Skip to main content

What the FDA labels say about taking them together

Cyclosporine and glyburide

Glyburide's FDA label of July 1, 2021 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name glyburide. The glyburide label: “Glyburide may increase cyclosporine plasma concentration and potentially lead to its increased toxicity.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the glyburide FDA label on DailyMed (effective July 1, 2021, TEVA Pharmaceuticals USA Inc).

What does the cyclosporine label say about glyburide?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name glyburide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the glyburide label say about cyclosporine?

Glyburide label, drug interactions

Glyburide may increase cyclosporine plasma concentration and potentially lead to its increased toxicity.

Source: FDA drug label (Glyburide), NDA017532 (Sanofi Aventis Us), as published by TEVA Pharmaceuticals USA Inc, effective July 1, 2021 (SPL set 50d16f1d-c814-4411-8749-62561321ecce), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
16Glyburide generic labelers
CyclosporineGlyburide
Labeled forOrgan transplant rejection, Rheumatoid arthritisType 2 diabetes
Boxed warningYesNo
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsion$0.0643 per tablet 5 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?